Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

| --- | --- |


		Page
(1)	Financial Statements

	Statements of Consolidated Income for the years ended October 27, 2024, October 29, 2023, and October 30, 2022	44

	Statements of Consolidated Comprehensive Income for the years ended October 27, 2024, October 29, 2023, and October 30, 2022	45

	Consolidated Balance Sheets as of October 27, 2024 and October 29, 2023	46

	Statements of Consolidated Cash Flows for the years ended October 27, 2024, October 29, 2023, and October 30, 2022	47

	Statements of Changes in Consolidated Stockholders’ Equity for the years ended October 30, 2022, October 29, 2023, and October 27, 2024	48

	Notes to Consolidated Financial Statements	49

(2)	Exhibits

	See the “Index to Exhibits” on pages 84 – 87 of this report

	Certain instruments relating to long-term borrowings constituting less than 10 percent of registrant’s total assets are not filed as exhibits herewith pursuant to Item 601(b)4(iii)(A) of Regulation S-K. The registrant agrees to file copies of such instruments upon request of the Commission.

Financial Statement Schedules Omitted

	The following schedules for the Company and consolidated subsidiaries are omitted because of the absence of the conditions under which they are required: I, II, III, IV, and V.